Yu Akazawa

9101193, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Spatial Proximity Between PD-L1(+) Tumor-Associated Macrophages and CD8(+) T Cells Influences Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma.

Spatial Proximity Between PD-L1(+) Tumor-Associated Macrophages and CD8(+) T Cells Influences Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma.

Journal: Cancers

Published: April 05, 2026

Metachronous severe multisystem immune-related adverse events during tremelimumab plus durvalumab therapy for hepatocellular carcinoma: a clinicopathological autopsy case report.

Metachronous severe multisystem immune-related adverse events during tremelimumab plus durvalumab therapy for hepatocellular carcinoma: a clinicopathological autopsy case report.

Journal: Frontiers in oncology

Published: March 14, 2026

Case Report: Elastography-negative acute fatty liver of pregnancy diagnosed by histopathology and electron microscopy.

Case Report: Elastography-negative acute fatty liver of pregnancy diagnosed by histopathology and electron microscopy.

Journal: Frontiers in medicine

Published: March 01, 2026

Alpha-1B Glycoprotein Is a Novel Hepatocyte-Derived Host Factor Associated with In Vitro Inhibition of HBV Replication and Hepatocellular Carcinoma Progression.

Alpha-1B Glycoprotein Is a Novel Hepatocyte-Derived Host Factor Associated with In Vitro Inhibition of HBV Replication and Hepatocellular Carcinoma Progression.

Journal: Cancers

Published: January 08, 2026

Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.

Complete response to Nivolumab-based chemotherapy in a case of advanced gastric cancer with multiple immune-related adverse events.

Journal: Clinical journal of gastroenterology

Published: October 21, 2025

PD-L1(+) tumor-associated macrophages induce CD8(+) T Cell exhaustion in hepatocellular carcinoma.

PD-L1(+) tumor-associated macrophages induce CD8(+) T Cell exhaustion in hepatocellular carcinoma.

Journal: Neoplasia (New York, N.Y.)

Published: August 31, 2025

Delayed Biliary Hemorrhage due to Pseudoaneurysm Rupture Caused by Migration of Placed Plastic Stent After Endoscopic Ultrasound-Guided Hepaticogastrostomy.

Delayed Biliary Hemorrhage due to Pseudoaneurysm Rupture Caused by Migration of Placed Plastic Stent After Endoscopic Ultrasound-Guided Hepaticogastrostomy.

Journal: DEN open

Published: August 19, 2025

Effective control in MSI-high unresectable intrahepatic cholangiocarcinoma treated with gemcitabine/cisplatin/durvalumab and proton beam therapy: a case report.

Effective control in MSI-high unresectable intrahepatic cholangiocarcinoma treated with gemcitabine/cisplatin/durvalumab and proton beam therapy: a case report.

Journal: Frontiers in immunology

Published: August 14, 2025

Clinical Significance of CD90(+) Circulating Tumor Cells as Dynamic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab and Lenvatinib.

Clinical Significance of CD90(+) Circulating Tumor Cells as Dynamic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab and Lenvatinib.

Journal: Cancers

Published: July 23, 2025

Proton Beam Therapy Provides Longer Survival and Preserves Muscle Mass in Hepatocellular Carcinoma Compared to TACE+RFA.

Proton Beam Therapy Provides Longer Survival and Preserves Muscle Mass in Hepatocellular Carcinoma Compared to TACE+RFA.

Journal: Cancers

Published: July 15, 2025

Successful treatment of β-catenin-positive, immune checkpoint inhibitor-resistant tumor in a case of multicentric hepatocellular carcinoma.

Successful treatment of β-catenin-positive, immune checkpoint inhibitor-resistant tumor in a case of multicentric hepatocellular carcinoma.

Journal: Clinical journal of gastroenterology

Published: April 28, 2025

Risk factors and long-term prognostic impact of immune related pancreatic injury in patients receiving immune checkpoint inhibitors.

Risk factors and long-term prognostic impact of immune related pancreatic injury in patients receiving immune checkpoint inhibitors.

Journal: Frontiers in immunology

Published: March 10, 2025

Showing 1-12 of 38

Last Updated: 09/26/2026